GlucoTrack, Inc. (GCTK)
2.93
-0.05
(-1.68%)
USD |
NASDAQ |
Sep 08, 16:00
2.97
+0.04
(+1.37%)
Pre-Market: 09:16
GlucoTrack Debt to Equity Ratio : -1.125 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.125 |
| March 31, 2026 | -4.216 |
| December 31, 2025 | 1.218 |
| September 30, 2025 | 1.199 |
| June 30, 2025 | 0.0388 |
| March 31, 2025 | 0.0361 |
| December 31, 2024 | -0.0205 |
| September 30, 2024 | -0.5607 |
| June 30, 2024 | -0.0833 |
| March 31, 2024 | 0.7234 |
| December 31, 2023 | 0.0613 |
| September 30, 2023 | 0.0331 |
| June 30, 2023 | 0.0244 |
| March 31, 2023 | 32.17 |
| December 31, 2022 | 0.1591 |
| September 30, 2022 | 0.0817 |
| June 30, 2022 | 0.0604 |
| March 31, 2022 | 0.0531 |
| December 31, 2021 | 0.0485 |
| September 30, 2021 | 0.0411 |
| June 30, 2021 | 0.0408 |
| March 31, 2021 | 0.0418 |
| December 31, 2020 | 0.0404 |
| September 30, 2020 | 0.0348 |
| June 30, 2020 | 0.0293 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0307 |
| December 31, 2019 | -0.2677 |
| September 30, 2019 | -0.3871 |
| June 30, 2019 | 22.97 |
| March 31, 2019 | -0.1386 |
| December 31, 2018 | -0.0585 |
| September 30, 2018 | -0.0674 |
| June 30, 2018 | -0.0482 |
| March 31, 2018 | -0.0626 |
| December 31, 2017 | -0.058 |
| September 30, 2017 | -0.1244 |
| June 30, 2017 | -0.367 |
| March 31, 2017 | -0.2867 |
| December 31, 2016 | -0.1784 |
| September 30, 2016 | -0.9875 |
| June 30, 2016 | 0.3051 |
| March 31, 2016 | -0.1499 |
| December 31, 2015 | -4.729 |
| September 30, 2015 | 0.1098 |
| June 30, 2015 | 0.0646 |
| March 31, 2015 | 0.0501 |
| December 31, 2014 | 0.2119 |
| September 30, 2014 | 0.3903 |
| June 30, 2014 | -0.2963 |
| March 31, 2014 | -0.0943 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Nuwellis, Inc. | -0.0978 |
| Abbott Laboratories | 0.638 |
| DexCom, Inc. | 0.5335 |
| Insulet Corp. | 0.6669 |
| AngioDynamics, Inc. | 0.0641 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.495M |
| Total Liabilities (Quarterly) | 3.236M |
| Shareholders Equity (Quarterly) | -1.741M |
| Current Ratio | 0.4622 |
| Net Debt Paydown Yield | -17.00% |